問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberES101002
NCT Number(ClinicalTrials.gov Identfier)-
Completed

2019-09-15 - 2024-01-30

Phase III

Recruiting5

Terminated2

ICD-10K51.90

Ulcerative colitis, unspecified, without complications

ICD-10K51.911

Ulcerative colitis, unspecified with rectal bleeding

ICD-10K51.912

Ulcerative colitis, unspecified with intestinal obstruction

ICD-10K51.913

Ulcerative colitis, unspecified with fistula

ICD-10K51.914

Ulcerative colitis, unspecified with abscess

ICD-10K51.918

Ulcerative colitis, unspecified with other complication

ICD-10K51.919

Ulcerative colitis, unspecified with unspecified complications

ICD-9556.9

Ulcerative colitis, unspecified

-

  • Trial Applicant

    COVANCE TAIWAN SERVICES LIMITED

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/15

Investigators and Locations

Principal Investigator Jen-Wei Chou Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Cheng-Tang Chiu Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 吳耿良 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 顏旭亨 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 黃天祐醫師 Division of Colorectal Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 顏志維 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    333 participants